Literature DB >> 25295746

Hardwiring patient blood management: harnessing information technology to optimize transfusion practice.

Nancy M Dunbar1, Zbigniew M Szczepiorkowski.   

Abstract

PURPOSE OF REVIEW: This review will describe recent applications of computerized provider order entry (CPOE) with clinical decision support systems (CDSS) in transfusion medicine and other novel ways information technology is being applied to support patient blood management (PBM) efforts. RECENT
FINDINGS: CPOE with CDSS can be used to encourage appropriate transfusion practices as part of an institutional PBM program. The impact of CPOE with CDSS is enhanced when the laboratory information system (LIS) can be linked to the electronic medical record (EMR) to enable adaptive alerts that query transfusion orders against current laboratory and/or clinical data to ensure provider ordering practice is consistent with institutional guidelines. Additional current applications of healthcare information technology to transfusion medicine include creation of electronic reports to support order auditing, assessment of blood product utilization and compliance monitoring.
SUMMARY: Application of healthcare information technology to transfusion medicine will expand, as more institutions embrace PBM and utilize their EMR and LIS to 'hardwire' appropriate transfusion practice. The impact of implementation of CPOE with CDSS is variable and influenced by multiple factors including existing practice patterns, provider receptiveness and system configuration.

Entities:  

Mesh:

Year:  2014        PMID: 25295746     DOI: 10.1097/MOH.0000000000000092

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  1 in total

1.  Electronic charting of transfusion medicine consults: implementation, challenges and opportunities.

Authors:  Mohammad K Mohammad; Melanie S Wooten; Cheryl L Maier; Charles E Hill; Jeannette Guarner; John D Roback; Anne M Winkler; Harold C Sullivan
Journal:  Vox Sang       Date:  2020-03-20       Impact factor: 2.144

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.